Mark L Perry Global Blood Therapeutics, Inc. (GBT) insider trading activity

GBT Quotes by TradingView

Mark L Perry is Director of Global Blood Therapeutics, Inc.. Currently has a direct ownership of 0 shares of GBT, which is worth approximately $0. The most recent transaction as insider was on Oct 05, 2022, when has been sold 37,865 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

MARK L PERRY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 05 2022
SELL
Sale (or disposition) back to the issuer
-
37,865 Reduced 100.0%
0 Common Stock
Jun 14 2022
BUY
Exercise of conversion of derivative security
-
3,600 Added 8.68%
37,865 Common Stock
Jun 17 2021
BUY
Exercise of conversion of derivative security
-
3,037 Added 8.14%
34,265 Common Stock

Also insider at

NVDA
NVIDIA CORP Technology
Director
MYOK
MyoKardia Inc
Director
MLP

Mark L Perry

Director
Santa Clara, CA

Track Institutional and Insider Activities on GBT

Follow Global Blood Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GBT shares.

Notify only if

Insider Trading

Get notified when an Global Blood Therapeutics, Inc. insider buys or sells GBT shares.

Notify only if

News

Receive news related to Global Blood Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GBT